Company: BOLT
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0000950170-25-058632
Chunk: 48

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 48
---
 grant date fair value of the stock options granted to the executive officer during 2024 or 2023, as applicable under our 2021 Equity Incentive Plan, computed in accordance with ASC 718. Assumptions used in the calculation of these amounts are included in Note 10 to our financial statements in our Form 10-K. (2) In May 2024, Mr. Quinn was appointed President and Chief Executive Officer and continues to serve as Chief Financial Officer. (3) Represents amounts earned in 2024, which were paid in 2025. Mr. Quinn's 2024 bonus was solely based on Company performance goals, while the 2024 annual performance bonuses for the other officers are based on a combination of Company performance goals and personal bonus achievements. For 2024, the compensation committee determined that we had achieved 100% of our Company goals. The 2024 personal bonus achievement was determined to be 100% for Mr.Yonehiro. (4) Mr. Quinn received $10,350 in 401(k) match. (5) Represents amounts earned in 2023, which were paid in 2024. Dr. Schatzman’s 2023 bonus was solely based on Company performance goals, while the 2023 annual performance bonuses for the other officers were based on a combination of Company performance goals and personal bonus achievements. For 2023, the compensation committee determined that we had achieved 80% of our Company goals. Accordingly, Dr. Schatzman was entitled to 80% of his target bonus. The 2023 personal bonus achievement was determined to be 95% for Dr. Perez and 100% for Messrs. Quinn and Yonehiro. (6) Mr. Quinn received $9,900 in 401(k) match. (7) In May 2024, Dr. Schatzman resigned as our Chief Executive Officer. (8) Includes payments to Dr. Schatzman of (i) $370,119 pursuant to our Severance and Change in Control Plan and (ii) $10,347 in 401(k) match. (9) Dr. Schatzman received $9,900 in 401(k) match. (10) In May 2024, Dr. Perez resigned as our Chief Medical Officer. (11) Includes payments to Dr. Perez of (i) $298,541 pursuant to our Severance and Change in Control Plan, (ii) $9,830 in 401